Roivant Sciences Ltd. Common Shares ROIV

$41.81 +0.80% at last close

Recent SEC Filings

FormDescriptionFiledDocument
8-K 8-K 2026-09-08 View →
4 FORM 4 2026-09-01 View →
8-K 8-K 2026-08-28 View →
8-K 8-K 2026-08-27 View →
4 FORM 4 2026-08-24 View →
4 FORM 4 2026-08-24 View →
4 FORM 4 2026-08-21 View →
4 Insider transaction 2026-08-18 View →
10-Q 10-Q 2026-08-06 View →
8-K 8-K 2026-08-06 View →
4 FORM 4 2026-07-29 View →
DEF 14A DEF 14A 2026-07-29 View →
4 FORM 4 2026-07-21 View →
4 FORM 4 2026-07-21 View →
4 FORM 4 2026-07-21 View →
4 FORM 4 2026-07-02 View →
4 FORM 4 2026-07-02 View →
4 FORM 4 2026-07-02 View →
4 FORM 4 2026-07-02 View →
4 FORM 4 2026-07-01 View →
4 4 2026-06-30 View →
4 4 2026-06-30 View →
4 4 2026-06-30 View →
4 FORM 4 2026-06-29 View →
4 FORM 4 2026-06-26 View →
4 FORM 4 2026-06-23 View →
4 FORM 4 2026-06-23 View →
4 FORM 4 2026-05-22 View →
4 FORM 4 2026-05-22 View →
10-K 10-K 2026-05-20 View →
8-K 8-K 2026-05-20 View →
4 FORM 4 2026-04-22 View →
4 FORM 4 2026-04-22 View →
4 FORM 4 2026-04-22 View →
4 FORM 4 2026-04-21 View →
4 FORM 4 2026-04-21 View →
4 FORM 4 2026-04-21 View →
4 FORM 4 2026-04-20 View →
4 FORM 4 2026-04-10 View →
4 FORM 4 2026-04-02 View →

Filings are sourced directly from the SEC's EDGAR system. Annual reports (10-K) and quarterly reports (10-Q) carry the full financial statements; 8-K filings disclose material events between reports; Form 4 filings record insider purchases and sales.

Key Stats

Last Close
$41.81
Market Cap
$30.20 billion
52-Week Range
$10.90 $42.50
Average Volume
7.84 million shs

Data is delayed and provided for informational purposes only. Not investment advice. See our disclaimer.